cambridge healthtech institute - cambridge …...immunogenicity summit october 10-12, 2012 •...
TRANSCRIPT
healthtech.comCambridge Healthtech Institute250 First Avenue, Suite 300 | Needham, MA 02494T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288 | F: (781) 972-5425
Your Life Science NetworkCambridge Healthtech Institute
O c t O b e r 2 0 1 2 - a p r i l 2 0 1 3
Conference & Course CatalogOctober 2012
through
April 2013
Cambridge20 Years of Being
Healthtech InstituteYour Life Science Network
2 | Cambridge Healthtech Institute
Cambridge Healthtech InstituteFor the past 20 years, Cambridge Healthtech Institute has developed more than 700 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.
Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.
For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.
AbOuT CHI
TAble OF COnTenTs
COnFerenCe serIes
Biologicial Therapeutic Products ................................................. 4
Biomarkers and Diagnostics ...................................................... 4
Bioprocess and Manufacturing .................................................. 4
Clinical Trials & Translational Medicine ........................................ 5
Chemistry .................................................................................. 5
BioPharmaceutical Strategy ....................................................... 6
Drug Discovery & Development ................................................ 6
Drug Device & Safety ................................................................. 6
Drug Targets ............................................................................... 7
Genomics ................................................................................... 7
Healthcare .................................................................................. 7
Informatics and IT ...................................................................... 7
Therapeutic Indications .............................................................. 8
Technology for Tools and Life Sciences ...................................... 8
COnFerenCes by DATe wITH DeTAIl .............................. 10-13
sHOrT COurse sCHeDule ...............................................14-15
CUSTOMER SERVICEPamela GerardiDirector of Customer ServiceE: [email protected] | T: 781-972-5409
Kris WatermanCustomer Service RepresentativeE: [email protected] | T: 781-972-5413
Rose LaRaiaCustomer Service RepresentativeE: [email protected] | T: 781-972-5400
MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441
Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456
SpONSOR & ExhIbIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467
Carol DinersteinDirector, Business DevelopmentE: [email protected] | T: 781-972-5471
GROUp SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472
GRAphICSThomas NortonProduction ManagerE: [email protected] | T: 781-972-5440
pRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423
Christina LinghamExecutive Director of ConferencesE: [email protected] | T: 781-972-5464
Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497
Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139
Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709
COnTACT us
October 2012 - April 2013 Catalog | 3
February 11-15, 2013Moscone North Convention Center San Francisco, CA
TriConference.com
April 29-May 3, 2013World Trade Center Boston, MA
PEGSummit.com
The Protein Science Week
January 21-25, 2013Renaissance Hotel & Palm Springs Convention CenterPalm Springs, CA
CHI-PepTalk.com
April 9-11, 2013World Trade Center Boston, MA
Bio-ITWorldExpo.com
April 16-18, 2013Hilton San Diego Resort San Diego, CA
DrugDiscoveryChemistry.com
Key evenTs
May 6-8, 2013Loews Philadelphia Hotel Philadelphia, PA
BiomarkerWorldCongress.com
June 4-6, 2013Loews Philadelphia Hotel Philadelphia, PA
WorldPharmaCongress.com
August 20-22, 2013Hyatt Regency Washington on Capitol HillWashington, DC
NextGenerationDX.com
One Stop Shop for Hundreds of Life Science Reports
AFFILIATED REPORTSCOLLECTION
An essential collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity
Over 300 reports available through our proprietary report collection and throughout a network of approved resellers. Some topics include:
n Clinical Trials and CROn Cancer Research and Therapeuticsn Biomarkers and Diagnostics
n Informatics and ITn Healthcare and Personalized Medicine
To learn more about Insight Pharma Reports, visit InsightPharmaReports.comFor more information, contact Rose LaRaia at [email protected] or call (781) 972-5444
Insight Pharma Reports, a division of Cambridge Healthtech Institute
February 5-7, 2013Hyatt Regency MiamiMiami, FL
SCOPESummit.com
4 | Cambridge Healthtech Institute
Conferences by Series
Immunogenicity summit October 10-12, 2012 • Bethesda, MD
PK/PD of novel Constructs October 10-12, 2012 • Bethesda, MD
PeGs europe: Protein & Antibody engineering summit November 6-8, 2012 • Vienna Austria
enhancing Protein expression and Achieving Higher Throughput November 6, 2012 • Vienna Austria
novel Antibody Constructs: Creative engineering, Delivery Technologies & Targeting November 6, 2012 • Vienna Austria
solving Difficult Protein Problems November 7, 2012 • Vienna Austria
novel Antibody Constructs: enhanced Product Properties & Therapeutic Application November 7, 2012 • Vienna Austria
PepTalk: The Protein science week January 21-25, 2013 • Palm Springs, CA
Optimizing biologics Formulation Development January 21-22, 2013 • Palm Springs, CA
Protein-Device Combinations January 21-22, 2013 • Palm Springs, CA
recombinant Protein Therapeutics January 21-22, 2013 • Palm Springs, CA
engineering Genes, vectors, Constructs, and Clones January 21-22, 2013 • Palm Springs, CA
lyophilization and emerging Drying Technologies January 23-24, 2013 • Palm Springs, CA
Antibodies for the 21st Century January 23-24, 2013 • Palm Springs, CA
bispecific Antibody Therapeutics January 24-25, 2013 • Palm Springs, CA
Choosing, Designing and Optimizing Hosts and Platforms January 24-25, 2013 • Palm Springs, CA
Cell Therapy February 13-15, 2013 • San Francisco, CA
Cancer biologics February 13-15, 2013 • San Francisco, CA
micrornA: Targets and Tools for Therapeutic Development March 4-5, 2013 • Cambridge, MA
biotherapeutics Analytical summit March 11-14, 2013 • Baltimore, MD
Analytical Characterization for biotherapeuticsMarch 11-12, 2013 • Baltimore, MD
Comparability for Change Implementation and for biosimilarsMarch 13-14 • Baltimore, MD
biobanking Congress October 1-2, 2012 • Chapel Hill, NC
Consumer Genetics Conference October 3-5, 2012 • Boston, MA
bio-IT world Conference & expo europe October 9-11, 2012 • Vienna Austria
Clinical Genomics October 9-10, 2012 • Vienna Austria
Digital PCr Applications and Advances October 15-16, 2012 • San Diego, CA
Generating evidence for reimbursement Decisions: Diagnostics November 6-7, 2012 • Philadelphia, PA
Molecular Med TrI-COn February 11-15, 2013 • San Francisco, CA
emerging Molecular Diagnostics Partnering Forum February 11-12, 2013 • San Francisco, CA
Digital Pathology February 13-15, 2013 • San Francisco, CA
Molecular Diagnostics February 13-15, 2013 • San Francisco, CA
Personalized Diagnostics February 13-15, 2013 • San Francisco, CA
Cancer Molecular Markers February 13, 2013 • San Francisco, CA
Circulating Tumor Cells February 13-15, 2013 • San Francisco, CA
micrornA: Targets and Tools for Therapeutic Development March 4-5, 2013 • Cambridge, MA
X-Gen Congress & expo March 18-21, 2013 • San Diego, CA
bio-IT world Conference & expo April 9-11, 2013 • Boston, MA
Immunogenicity summit October 10-12, 2012 • Bethesda, MD
Immunogenicity Assessment & Clinical relevance October 10, 2012 • Bethesda, MD
Immunogenicity Prediction & Mitigation October 11, 2012 • Bethesda, MD
PeGs europe: Protein & Antibody engineering summit November 6-8, 2012 • Vienna Austria
enhancing Protein expression and Achieving Higher Throughput November 6, 2012 • Vienna Austria
October 2012 - April 2013 Catalog | 5
Conferences by Series
novel Antibody Constructs: Creative engineering, Delivery Technologies & Targeting November 6, 2012 • Vienna Austria
solving Difficult Protein Problems November 7, 2012 • Vienna Austria
PepTalk: The Protein science week January 21-25, 2013 • Palm Springs, CA
Optimizing biologics Formulation Development January 21-22, 2013 • Palm Springs, CA
Protein-Device Combinations January 21-22, 2013 • Palm Springs, CA
Protein Purification and recovery January 21-22, 2013 • Palm Springs, CA
lyophilization and emerging Drying Technologies January 23-24, 2013 • Palm Springs, CA
Higher Throughput Protein Purification January 23-24, 2013 • Palm Springs, CA
Fine-Tuning expression in CHO January 23-24, 2013 • Palm Springs, CA
Protein Aggregation and emerging Analytical Tools January 24-25, 2013 • Palm Springs, CA
Choosing, Designing and Optimizing Hosts and Platforms January 24-25, 2013 • Palm Springs, CA
extractables and leachables January 24-25, 2013 • Palm Springs, CA
biotherapeutics Analytical summit March 11-14, 2013 • Baltimore, MD
Analytical Characterization for biotherapeuticsMarch 11-12, 2013 • Baltimore, MD
Comparability for Change Implementation and for biosimilarsMarch 13-14 • Baltimore, MD
biobanking Congress October 1-2, 2012 • Chapel Hill, NC
Consumer Genetics Conference October 3-5, 2012 • Boston, MA
CHI’s barnett Clinical summit October 9-12, 2012 • Cambridge, MA
virtual Investigator Meeting Management October 9-10, 2012 • Cambridge, MA
Clinical Protocol Development October 9-10, 2012 • Cambridge, MA
Clinical Project Management October 11-12, 2012 • Cambridge, MA
Clinical Training Forum October 11-12, 2012 • Cambridge, MA
From Drug Discovery Informatics to Personalized Therapeutics October 10-11, 2012 • Vienna Austria
PK/PD of novel Constructs October 10-12, 2012 • Bethesda, MD
summit for Clinical Ops executives (sCOPe) February 5-7, 2013 • Miami, FL
electronic Data in Clinical Trials February 5-6, 2013 • Miami, FL
Global site selection, Feasibility Assessment, Operations and site Management February 5-6, 2013 • Miami, FL
Implementing and Managing strategic Alliances February 5-6, 2013 • Miami, FL
Post-Marketing studies as a Tool for safety, Outcomes and Comparative effectiveness research February 5-6, 2013 • Miami, FL
Managing Post-Marketing studies and registries February 6-7, 2013 • Miami, FL
Integrating and leveraging Clinical Trial Operations Data February 6-7, 2013 • Miami, FL
Patient recruitment and retention in studies and registries February 6-7, 2013 • Miami, FL
Clinical Trial Forecasting, budgeting and Project Management February 6-7, 2013 • Miami, FL
Oncology Clinical Trials February 13-15, 2013 • San Francisco, CA
Clinical and Translational science February 13-15, 2013 • San Francisco, CA
Predictive Pre-Clinical Models in Oncology February 13-15, 2013 • San Francisco, CA
bio-IT world Conference & expoApril 9-11, 2013 • Boston, MA
Discovery on Target October 1-3, 2012 • Boston, MA
GPCr-based Drug Discovery October 1-2, 2012 • Boston, MA
novel strategies for Kinase Inhibitors October 1-2, 2012 • Boston, MA
Advances in Targeting the PI3K Pathway October 2-3, 2012 • Boston, MA
Functional Genomics screening strategies October 2-3, 2012 • Boston, MA
High-Content Analysis January 8-11, 2013 • San Francisco, CA
Mastering Medicinal Chemistry February 13-15, 2013 • San Francisco, CA
bio-IT world Conference & expo April 9-11, 2013 • Boston, MA
Drug Discovery ChemistryApril 16-18, 2013 • San Diego, CA
6 | Cambridge Healthtech Institute
Conferences by Series
Consumer Genetics Conference October 3-5, 2012 • Boston, MA
Accelerating Proof of Concept November 5-6, 2012 • Philadelphia, PA
Generating evidence for reimbursement Decisions: Therapeutics November 5-6, 2012 • Philadelphia, PA
Generating evidence for reimbursement Decisions: Diagnostics November 6-7, 2012 • Philadelphia, PA
strategic resource Management November 5-6, 2012 • Philadelphia, PA
Portfolio Management November 6-7, 2012 • Philadelphia, PA
summit for Clinical Ops executives (sCOPe) February 5-7, 2013 • Miami, FL
Implementing and Managing strategic Alliances February 5-6, 2013 • Miami, FL
Clinical Trial Forecasting, budgeting and Project Management February 6-7, 2013 • Miami, FL
Molecular Med TrI-COn February 11-15, 2013 • San Francisco, CA
emerging Molecular Diagnostics Partnering Forum February 11-12, 2013 • San Francisco, CA
Discovery on Target October 1-3, 2012 • Boston, MA
novel strategies for Kinase Inhibitors October 1-2, 2012 • Boston, MA
next-Generation Histone Deacetylase Inhibitors October 1-2, 2012 • Boston, MA
GPCr-based Drug Discovery October 1-2, 2012 • Boston, MA
Targeting Cancer Cell Metabolism October 1-2, 2012 • Boston, MA
Targeting the ubiquitin Pathway October 1-2, 2012 • Boston, MA
Advances in Targeting the PI3K Pathway October 2-3, 2012 • Boston, MA
Functional Genomics screening strategies October 2-3, 2012 • Boston, MA
biobanking Congress October 1-2, 2012 • Chapel Hill, NC
bio-IT world Conference & expo europe October 9-11, 2012 • Vienna Austria
From Drug Discovery Informatics to Personalized Therapeutics October 10-11, 2012 • Vienna Austria
Cloud-based bioinformatics October 10-11, 2012 • Vienna Austria
Accelerating Proof of Concept November 5-6, 2012 • Philadelphia, PA
Generating evidence for reimbursement Decisions: Therapeutics November 5-6, 2012 • Philadelphia, PA
strategic resource Management November 5-6, 2012 • Philadelphia, PA
Portfolio Management November 6-7, 2012 • Philadelphia, PA
High-Content Analysis January 8-11, 2013 • San Francisco, CA
Molecular Med TrI-COnFebruary 11-15, 2013 • San Francisco, CA
Predictive Pre-Clinical Models in Oncology February 13-15, 2013 • San Francisco, CA
micrornA:Targets and Tools for Therapeutic Development March 4-5, 2013 • Cambridge, MA
bio-IT world Conference & expo April 9-11, 2013 • Boston, MA
Drug & DeviceSafety Series
Immunogenicity summit October 10-12, 2012 • Bethesda, MD
Immunogenicity Assessment & Clinical relevance October 10, 2012 • Bethesda, MD
Immunogenicity Prediction & Mitigation October 11, 2012 • Bethesda, MD
Protein-Device Combinations January 21-22, 2013 • Palm Springs, CA
Protein Aggregation and emerging Analytical Tools January 24-25, 2013 • Palm Springs, CA
extractables and leachables January 24-25, 2013 • Palm Springs, CA
Post-Marketing studies as a Tool for safety, Outcomes and Comparative effectiveness research February 5-6, 2013 • Miami, FL
Managing Post-Marketing studies and registries February 6-7, 2013 • Miami, FL
October 2012 - April 2013 Catalog | 7
Conferences by Series
Drug TargetsSERIES
Discovery on Target October 1-3, 2012 • Boston, MA
novel strategies for Kinase Inhibitors October 1-2, 2012 • Boston, MA
next-Generation Histone Deacetylase Inhibitors October 1-2, 2012 • Boston, MA
GPCr-based Drug Discovery October 1-2, 2012 • Boston, MA
Targeting Cancer Cell Metabolism October 1-2, 2012 • Boston, MA
Targeting the ubiquitin Pathway October 1-2, 2012 • Boston, MA
Advances in Targeting the PI3K Pathway October 2-3, 2012 • Boston, MA
Allosteric Modulators October 2-3, 2012 • Boston, MA
Functional Genomics screening strategies October 2-3, 2012 • Boston, MA
Diabetes Drug Discovery and beyond October 2-3, 2012 • Boston, MA
Targeting Histone Methyltransferases and Demethylases October 2-3, 2012 • Boston, MA
biobanking Congress October 1-2, 2012 • Chapel Hill, NC
Generating evidence for reimbursement Decisions: Diagnostics November 6-7, 2012 • Philadelphia, PA
PeGs europe: Protein & Antibody engineering summit November 6-8, 2012 • Vienna Austria
micrornA: Targets and Tools for Therapeutic Development March 4-5, 2013 • Cambridge, MA
X-Gen Congress & expo March 18-21, 2013 • San Diego, CA
Functional Genomics screening strategies October 2-3, 2012 • Boston, MA
Consumer Genetics Conference October 3-5, 2012 • Boston, MA
Clinical Genomics October 9-10, 2012 • Vienna Austria
Digital PCr Applications and Advances October 15-16, 2012 • San Diego, CA
Digital Pathology February 13-15, 2013 • San Francisco, CA
bioinformatics in the Genome era February 13-15, 2013 • San Francisco, CA
X-Gen Congress & expo March 18-21, 2013 • San Diego, CA
Healthcare Series
Consumer Genetics Conference October 3-5, 2012 • Boston, MA
barnett’s Clinical summit October 9-12, 2012 • Cambridge, MA
Clinical Genomics October 9-10, 2012 • Vienna Austria
Immunogenicity Assessment & Clinical relevance October 10, 2012 • Bethesda, MD
Digital Pathology February 13-15, 2013 • San Francisco, CA
Medical Informatics world Conference April 8-9, 2013 • Boston, MA
Consumer Genetics Conference October 3-5, 2012 • Boston, MA
virtual Investigator Meeting Management October 9-10, 2012 • Cambridge, MA
Clinical Protocol Development October 9-10, 2012 • Cambridge, MA
bio-IT world Conference & expo europe October 9-11, 2012 • Vienna Austria
Data Infrastructure and High Performance Computing October 9-10, 2012 • Vienna Austria
From Drug Discovery Informatics to Personalized Therapeutics October 10-11, 2012 • Vienna Austria
8 | Cambridge Healthtech Institute
Conferences by Series
Cloud-based bioinformatics October 10-11, 2012 • Vienna Austria
electronic Data in Clinical Trials February 5-6, 2013 • Miami, FL
Post-Marketing studies as a Tool for safety, Outcomes and Comparative effectiveness research February 5-6, 2013 • Miami, FL
Integrating and leveraging Clinical Trial Operations Data February 6-7, 2013 • Miami, FL
Integrated r&D Informatics and Knowledge Management February 13-15, 2013 • San Francisco, CA
bioinformatics in the Genome era February 13-15, 2013 • San Francisco, CA
Medical Informatics world Conference April 8-9, 2013 • Boston, MA
bio-IT world Conference & expoApril 9-11, 2013 • Boston, MA
SERIESnovel strategies for Kinase Inhibitors October 1-2, 2012 • Boston, MA
next-Generation Histone Deacetylase Inhibitors October 1-2, 2012 • Boston, MA
GPCr-based Drug Discovery October 1-2, 2012 • Boston, MA
Targeting Cancer Cell Metabolism October 1-2, 2012 • Boston, MA
Targeting the ubiquitin Pathway October 1-2, 2012 • Boston, MA
Diabetes Drug Discovery and beyond October 2-3, 2012 • Boston, MA
Targeting Histone Methyltransferases and Demethylases October 2-3, 2012 • Boston, MA
biobanking Congress October 1-2, 2012 • Chapel Hill, NC
From Drug Discovery Informatics to Personalized Therapeutics October 10-11, 2012 • Vienna Austria
PK/PD of novel Constructs October 10-12, 2012 • Bethesda, MD
micrornA: Targets and Tools for Therapeutic DevelopmentMarch 4-5, 2013 • Cambridge, MA
Discovery on Target October 1-3, 2012 • Boston, MA
Functional Genomics screening strategies October 2-3, 2012 • Boston, MA
biobanking Congress October 1-2, 2012 • Chapel Hill, NC
Data Infrastructure and High Performance Computing October 9-10, 2012 • Vienna Austria
Digital PCr Applications and Advances October 15-16, 2012 • San Diego, CA
enhancing Protein expression and Achieving Higher Throughput November 6, 2012 • Vienna Austria
High-Content Analysis January 8-11, 2013 • San Francisco, CA
engineering Genes, vectors, Constructs, and Clones January 21-22, 2013 • Palm Springs, CA
Protein Aggregation and emerging Analytical Tools January 24-25, 2013 • Palm Springs, CA
bioinformatics in the Genome era February 13-15, 2013 • San Francisco, CA
micrornA: Targets and Tools for Therapeutic Development March 4-5, 2013 • Cambridge, MA
Educational DVDs are one of many assets available from the Cambridge Healthtech Institute Life Science Media Library.
LIFE SCIENCE
MEDIALIBRARY Order and view all our DVDs at healthtech.com/medialibrary
Cambridge Healthtech Institute Go Beyond The Session RoomDVDs of Short Courses and Workshops allow you to navigate, pause, rewind and listen to recorded sessions in a multimedia presentation.
WHITEPAPERS PODCASTS
DVDS
WHITEPAPERS
PODCASTS
DVDS
WEBINARS
WEBINARS
October 2012 - April 2013 Catalog | 9
Conferences by SeriesPublications Available Through CHI
An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D ProductivityNewly Published Reports:•Alzheimer’sDisease•TheNewGenerationofAntibodyTherapeutics•Fragment-BasedDrugDiscovery•Back-UpCompoundStrategies•HematologicalCancerTherapies:Pipelines,Markets,andBusinessConsiderations
Coming Soon!•SolidTumorTherapies:Pipelines,Markets,BusinessConsiderations•ComboRx/Dx•ClinicalGenomics
The Affiliated Reports Collection are approved reports of Insight Pharma Reports
Topics Include:•CancerResearch&Therapeutics•Biomarkers&Diagnostics•Mergers&Acquisitions•Biosimilars&Generics•DrugDiscovery•HealthcareandPersonalizedMedicine•ClinicalTrialsandCRO•BloodDisordersandDisease
•RespiratoryDiseaseandTherapeutics•PharmaceuticalMarketing
Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools and personalized medicine.• Bio-IT World Weekly Update Newsletter Deliveredweekly,focusingonthelatestindustrynews,commentaryandhighlightsfromBio-ITWorld
• Bio-IT World Resource Alert Deliveredweeklywithcomplimentaryindustryresources• Bio-IT World News Bulletins Deliveringbreakingnewswithintheindustry,asithappens
eCliniqua provides authoritative news, views and insights on management challenges related to innovative clinical trials management, implementation processes, technology solutions and much more.
• eCliniqua Newsletter Deliveredmonthly,focusingoninnovativemanagementinClinicalTrials
• eCliniqua Resource Alert Deliveredbi-weeklywithcomplimentaryindustryresources
Stay Informed. Remain Competitive. Subscribe Today.Bio-ITWorld.com l eCliniqua.com
For More Information, Visit: InsightPharmaReports.com
Cambridge Healthtech Institute250FirstAvenue,Suite300,Needham,MA02494,USAlP:781.972.5400lF:781.972.5425lwww.chicorporate.com
Innovative management in clinical trials
10 | Cambridge Healthtech Institute
October 1-3, 2012 • Boston, MA
Discovery on Target offers the opportunity to explore current “hot” targets, such as GPCRs, Kinases and Histone Deacetylase as well as to discover the “new kids on the block” which show a very promising future, such as Ubiquitin, Histone Methyl Transferases and PI3K. In addition, new developments and strategies to target some of the most prevalent diseases are being presented in focused meetings such as Cancer Cell Metabolism, Diabetes Drug Discovery, Allosteric Modulators and Functional Genomic Screening Strategies.
Celebrating 10 years, Cambridge Healthtech Institute’s “Discovery on Target” is a leading event, recognized and well attended by the pharmaceutical and biotech industry and academic institutions alike.
DiscoveryOnTarget.com
biobanking Congress October 1-2, 2012 • Chapel Hill, NC
Today, biospecimen collections are used by multiple research groups for various research aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. The proper collection, processing, storage, and tracking of biospecimens are vital components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. Cambridge Healthtech Institute’s fourth annual Leaders in Biobanking Congress addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best tactics for effective use of biospecimens within today’s cutting edge research.
healthtech.com/BioBanking
Consumer Genetics Conference October 3-5, 2012 • Boston, MA
The Consumer Genetics Conference (CGC) covers the key issues facing clinical genetics, personalized medicine, molecular diagnostics, and consumer-targeted DNA applications. It provides a unique outlet where all voices can be heard: pro & con, physician & consumer, research & clinical, academic & corporate, financial & regulatory.
ConsumerGeneticsConference.com
CHI’s barnett Clinical summit: Optimizing Trial Performance October 9-12, 2012 • Cambridge, MA
Cambridge Healthtech Institute (CHI) and Barnett International have co-organized the second annual Barnett Clinical Summit: Optimizing Trial Performance which features four co-located conferences: Virtual Protocol Development, Virtual Investigator Meeting Management, Clinical Training Forum, and Clinical Project Management Forum. This four-day summit will include formal presentations from experts, as well as case studies, interactive breakout discussion groups, workshops and networking opportunities, and will provide a forum for all involved in clinical trials to share ideas, proven practices, and recent research findings. It is also an excellent opportunity to socialize and interact with colleagues from around the world who are facing similar challenges and utilizing tested strategies.
BarnettClinicalSummit.com
bio-IT world Conference & expo europe October 9-11, 2012 • Vienna Austria
The Fourth Annual Bio-IT World Europe Conference & Expo attracts life sciences, pharmaceutical, informatics and IT professionals from across Europe and the rest of the world to the magnificent cultural location of Vienna, Austria. The venue provides a stimulating three days to share research advances, information trends and new enabling technologies that are driving biomedical research and drug development to new heights. This year’s Bio-IT World Europe will feature four tracks, each running a day and a half, providing dynamic discussion from world-leading scientists in Clinical Genomics; Data Infrastructure and High Performance Computing; Drug Discovery Informatics to Personalized Therapeutics; and Cloud-Based Bioinformatics.
Bio-ITWorldExpoEurope.com
Immunogenicity summit 2012 October 10-12, 2012 • Bethesda, MD
Following year-on-year success, CHI presents their fourth Immunogenicity Summit. We will continue to provide strong interaction and discussion with the regulatory authorities (40 FDA representatives in 2011), updates on immunogenicity testing strategies and means of controlling immunogenicity. New this year will be a focus on characterization and impact of immune complexes, in vivo assessment with immune tolerant mice, and anti-idiotype assays for hypersensitivity. Last year’s attendance was up by 20% with over 250 attendees representing over 50 global organizations.
ImmunogenicitySummit.com
Conferences by Date with Detail
FOllOw us
@CHI_Healthtechlinkedin.com/company/cambridge-healthtech-institute
October 2012 - April 2013 Catalog | 11
PK/PD of novel Constructs October 10-12, 2012 • Bethesda, MD
Understanding the metabolism of novel constructs in animal models and clinical studies is critical to their success. There are numerous constructs of bispecific and multiclonal antibodies, antibody-drug conjugates, and antibody fragments heading to the clinic that are diverse in nature. This conference will delve into tools for understanding effects in humans and engineering for optimal efficacy, safety and metabolism, and strive to uncover the link between immunogenicity and pK/pD.
healthtech.com/Novel-Constructs
Digital PCr Applications and Advances October 15-16, 2012 • San Diego, CA
Over a decade ago, real-time PCR set the standard for sensitive DNA quantification with researchers relying heavily on the process for disease research, diagnosis, and preventative medicine. Today, digital PCR is poised to make a significant impact in the diagnostics field. By allowing for detection of nucleic acids at higher resolution and lower target levels, digital PCR has the ability to identify diseases earlier in progression, providing an advantage for diagnostics and preventative medicine. Its ability to precisely analyze nucleic acids at a molecular level makes it ideal for tasks such as detecting copy number variation and point mutations. This meeting will evaluate novel digital PCR technologies for research, demonstrate innovative amplification techniques, and present strategies for solving common research bottlenecks.
healthtech.com/Digital-PCR
Accelerating Proof of Concept November 5-6, 2012 • Philadelphia, PA
The fourth annual Accelerating Proof-of-Concept conference, being held November 5-6, 2012 will feature industry and academic experts discussing the latest in patient stratification theories and strategies, comparative effectiveness in the PoC stages, and the role of precision medicine in accelerating PoC. The trend of in-licensing molecules to keep the development pipeline fed will be examined, as PoC strategies may differ for “optioned entities.” Presentations will focus on strategic and scientific advances and methods to accelerate PoC. Key opinion leaders from the pharma industry will also provide updates on topics such as accelerated approval. Accelerated PoC strategies will be highlighted in this year’s program..
healthtech.com/Proof-Of-Concept
Generating evidence for reimbursement Decisions: Therapeutics November 5-6, 2012 • Philadelphia, PA
It is important to formulate goals for generating, collecting, and analyzing reimbursement evidence early in product development in order to ensure commercial success of a drug or a biologics. We are witnessing the emergence of a new integrated strategy while the biopharmaceutical industry is partnering up with payers to develop evidence of a product’s validity and utility as well as comparative clinical and cost effectiveness. The inaugural
Generating Evidence for Reimbursement Decisions: Therapeutics conference is designed to bring together all major stakeholders in the field of evidence-based reimbursement, clinical development experts, reimbursement and government affairs specialists, health care economists and payers. The conference will be directly followed by Generating Evidence for Reimbursement Decisions: Diagnostics conference.
healthtech.com/Therapeutics-Reimbursement
Generating evidence for reimbursement Decisions: Diagnostics November 6-7, 2012 • Philadelphia, PA
Achieving commercial success for an IVD product or device is becoming progressively more difficult in the current healthcare environment. The combination of tightening health care budget and launch of a large number of expensive molecular tests creates complications for payers to respond in traditional ways. Comprehensive clinical data and pharma-type clinical trials have increasingly become the condition of getting a test reimbursed. The inaugural Generating Evidence for Reimbursement Decisions: Diagnostics conference is designed to bring together major players the field of evidence-based reimbursement in diagnostics. The conference will be preceded by Generating Evidence for Reimbursement Decisions: Therapeutics conference.
healthtech.com/Diagnostics-Reimbursement
strategic resource Management November 5-6, 2012 • Philadelphia, PA
Strategic decision-making about resource acquisition, allocation, development, and optimization is key to maintaining a competitive advantage in today’s economy for leading life science companies. CHI’s and the BioPharma Strategy Series’ tenth annual Strategic Resource Management conference, held November 5-6, 2012 at the Hyatt Regency Philadelphia in Philadelphia, PA, brings together key decision makers and industry thought leaders for valuable presentations and discussions on solutions to today’s resource management issues.
ExecutiveDecisionMaking.com/ResourceManagement
PeGs europe November 6-8, 2012 • Vienna Austria
The 4th Annual PEGS Europe Summit is the leading European protein and antibody engineering event of the year and will be held at the InterContinental Hotel in Vienna, Austria from November 6-8, 2012. Program topics include:
• Enhancing Protein Expression & Achieving Higher Throughput• Solving Difficult Protein Problems• Engineering Novel Antibody Constructs & Alternative Scaffolds• Therapeutic Developments with Novel Antibody Products
PEGSummitEurope.com
Conferences by Date with Detail
12 | Cambridge Healthtech Institute
Portfolio Management November 6-7, 2012 • Philadelphia, PA
Portfolio management is a powerful strategic tool to increase R&D capabilities, innovation, and company growth for today’s leading life science companies. Yet, there is significant debate on best approaches for obtaining and maintaining optimum selection and balance in pharmaceutical portfolios. CHI’s and the BioPharma Strategy Series’ seventh annual Portfolio Management conference, held November 6-7, 2012 at the Hyatt Regency Philadelphia in Philadelphia, PA, brings together key decision makers and industry thought leaders from leading life science companies for crucial discussions and presentations on principles and methodologies for effective portfolio management.
ExecutiveDecisionMaking.com/PortfolioManagement
High-Content Analysis January 8-11, 2013 • San Francisco, CA
Please join us in celebrating the 10th anniversary of CHI’s High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Tenth Annual High-Content Analysis 2013 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, and novel biological models for screening. We will also cover case studies and applications in compound screening, cytotoxicity evaluation, stem cell research, functional analysis, and more
HighContentAnalysis.com
The Protein Science Week
January 21-25, 2013 • Palm Springs, CA
CHI’s PepTalk: The Protein Science Week is more than just a conference. It is a community dedicated to the evolving field of biotherapeutics and a gateway to the future of biologics.
The continuous growth and success of PepTalk is due to the commitment and quality of scientific programming. Join us January 21-25 in Palm Springs, California to learn about the advances and debate the challenges in protein-based therapeutics.
CHI-PepTalk.com
February 5-7, 2013 • Miami, FLThe Summit for Clinical Trials Operations Executives (SCOPE): Overcoming Key Challenges in Forecasting, Site Selection, Recruitment, Data Collection and Project Management is taking place February 5-7, 2013 in Miami, FL. The program will offer eight conferences and six pre-conference short courses. Each conference will feature best practice case studies relevant to clinical operations experts and those new to the field.
ScopeSummit.com
February 11-15, 2013 • San Francisco, CA
The 20th International Molecular Med Tri-Conference is the leading drug discovery research event covering a broad spectrum of cutting-edge topics within molecular medicine with scientific, business and regulatory viewpoints.
Join over 3,000 of your colleagues in interactive lectures, discussions, and various networking receptions to hear differing views and perspectives on poignant issues facing you and our industry today. Spanning five days, the Tri-Conference includes 5 Concurrent Symposia, the Emerging Molecular Diagnostics Partnering Forum, 15 Afternoon & Dinner Short Courses and 15 Conference Programs.
bioinformatics in the Genome era
Integrated r&D Informatics and Knowledge Management
Molecular Diagnostics
Mastering Medicinal Chemistry
Personalized Diagnostics
Cancer Molecular Markers
Circulating Tumor Cells
Digital Pathology - new
Cell Therapy - new
Cancer biologics
Clinical and Translational science
Clinical sequencing - new
Cancer Molecular Markers
Predictive Pre-clinical Models in Oncology - new
Oncology Clinical Trials
TriConference.com
Conferences by Date with Detail
October 2012 - April 2013 Catalog | 13
micrornA: Targets and Tools for Therapeutic Development March 4-5, 2013 • Cambridge, MA
microRNAs are playing an important role in a range of diseases such as cancer, metabolic diseases and cardiovascular disorders. Their involvement in many physiological pathways, makes them an excellent target for pharmaceutical drug development and their use as biomarkers or for profiling and screening turns them into a valuable tool for diagnostics. This conference highlights novel developments in using miRNA’s for health and disease, it will discuss novel applications and progress made in manipulating microRNA and opportunities for using microRNA as a tool will also be explored.
healthtech.com/microRNA
biotherapeutics Analytical summit March 11-14, 2013 • Baltimore, MD
CHI’s Fourth Annual Biotherapeutics Analytical Summit will be taking place March 11-14, 2013 in Baltimore, Maryland. This event features 150+ industry, regulatory and biosimilar professionals gaining insight into analytical characterization and comparability for change implementation through case studies, interactive break-out discussions, networking opportunities and more!
BiotherapeuticsAnalyticalSummit.com
X-Gen Congress & expo March 18-21, 2013 • San Diego, CA
NGS has enabled faster and cheaper mapping of DNA/RNA, allowing genomic comparisons and accelerating genomic discoveries. Cambridge Healthtech Institute is proud to host the Fourth Annual X-Gen Congress and Expo, which is uniquely designed to cover these technological advances and discover advancing applications. With the focus now on clinical utility, find out why data analysis is the driving force that enables discovery, and is sequencing’s strategic step.
XGenCongress.com
Medical Informatics world Conference April 8-9, 2013 | Boston, MA
Taking place April 8-9, Cambridge Healthtech Institute’s and Bio-IT World’s Medical Informatics World 2013 will bring together industry leaders and decision makers in the fields of HIT, healthcare, biomedical sciences, life sciences, pharmaceuticals, informatics and IT in Boston, MA. Over the course of two stimulating days, senior level executives and leading experts will share research advances, information trends and new enabling technologies that are driving healthcare management, biomedical research, and healthcare delivery to new heights. Medical Informatics World 2013 will feature three tracks, each running a day and a half, and four in-depth half-day workshops providing dynamic discussion from world-leading scientists and executives in healthcare informatics, biomedical informatics, applied clinical informatics, and personalized medicine.
MedicalInformaticsWorld.com
April 9-11, 2013 | Boston, MA
The 2013 Expo plans to unite 2,500+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 30+ countries. The Expo provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.
Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The 2013 program will feature compelling talks from industry and academia on new trends in data generation, knowledge management, and information technology in life sciences and drug development, including best practice case studies and joint partner presentations relevant to the technologies, research, and regulatory issues of life science, pharmaceutical, clinical and IT professionals. Bio-IT World Conference & Expo continues to expand with the addition of two new Tracks: Data Visualization and Clinical Omics.
Spanning three days, the meeting includes 12 parallel conference tracks and 16 pre-conference workshops.
Bio-ITWorldExpo.com
Drug Discovery ChemistryApril 16-18, 2013 • San Diego, CA
Drug Discovery Chemistry is the leading discovery event in medicinal chemistry. Focused on novel small molecules as therapeutic targets, with a strong emphasis on a chemistry-based approach, this unique event brings together top experts with backgrounds in medicinal chemistry, biochemistry and life sciences to discuss cutting-edge research in the important areas of:
• Fragment-Based Drug Design: From Discovery to Lessons Learned
• Targeting Inflammation: Small Molecule Approaches• Kinase Inhibitor Chemistry: Charting the Chemical Space• Protein-Protein Interactions as Drug Targets• Anti-Virals: Small Molecule Candidates• Computation and Structure Based GPCR Drug Design
DrugDiscoveryChemistry.com
Conferences by Date with Detail
14 | Cambridge Healthtech Institute
Short Course Title Conference / Date / LocationDISCoVERy on TaRgET
Pre-Clinical Toxicity Prediction: From Strategies to Mechanisms September 30, 2012 • Boston, MA
Understanding and Targeting Protein-Protein Interactions September 30, 2012 • Boston, MA
Understanding Structure-and Fragment-Based Drug Discovery: Tools and Techniques September 30, 2012 • Boston, MA
Setting Up Effective Rnai Screens: getting From Design to Data October 2, 2012 • Boston, MA
allosteric Modulators: Putting Theory to Practice October 2, 2012 • Boston, MA
Epigenetic Drug Discovery Tools: October 2, 2012 • Boston, MA
BIoBankIng CongRESS
Collaboration and Biospecimen Sharing between Multiple Biorepositories September 30, 2012 • Chapel Hill, NC
BaRnETT ClInICal SUMMIT
Writing Successful Clinical Protocols October 9, 2012 • Cambridge, MA
Problem analysis Method overview October 10, 2012 • Cambridge, MA
Proactive approaches to Vendor Management October 10, 2012 • Cambridge, MA
Design Considerations for gCP Training Programs October 10, 2012 • Cambridge, MA
BIo-ITWoRlD EURoPE
Considerations for analyzing Targeted next-generation Sequencing Data October 8, 2012 • Vienna Austria
Software Considerations for Processing, analyzing and Interpreting Sequence Data October 8, 2012 • Vienna Austria
IMMUnogEnICITy SUMMIT
assays for Measuring Binding antibodies October 9, 2012 • Bethesda, MD
Development of neutralizing antibody assays October 9, 2012 • Bethesda, MD
Navigating the Regulatory Hierarchy of Concerns to Minimize Impact of Immunogenicity-Related Risks on Product Registration
October 9, 2012 • Bethesda, MD
Pk/PD oF noVEl ConSTRUCTS
Pk/PD Bioanalysis October 12, 2012 • Bethesda, MD
DIgITal PCR
Digital PCR: a Technology Primer October 15, 2012 • San Diego, CA
gEnERaTIng EVIDEnCE FoR REIMBURSEMEnT DECISIonS: THeRApeuTICS
Systems for Evidence Creation and Evidence Dossiers for Payers November 5, 2012 • philadelphia, pA
STRaTEgIC RESoURCE ManagEMEnT
Enhancing the Quality of Portfolio Decisions November 5, 2012 • philadelphia, pA
PEgS EURoPE
Measures to enhance Half-Life and Stability November 5, 2012 • Vienna Austria
Engineering of Bispecific antibodies November 5, 2012 • Vienna Austria
From Understanding of aggregation to Devising of Prevention Strategies November 5, 2012 • Vienna Austria
gEnERaTIng EVIDEnCE FoR REIMBURSEMEnT DECISIonS: DIagnoSTICS
Reimbursement of Cancer gene Expression Profiling November 6, 2012 • philadelphia, pA
PoRTFolIo ManagEMEnT
optimizing Trial Resourcing through operational Benchmarking & Ensuring alignment between Study goals and activities
November 6, 2012 • philadelphia, pA
Short Course Schedule HOLD A COuRSE AT yOuR fACiLiTy.For more information, please contact Edel o’Regan at 781-972-5423 or email: [email protected]
October 2012 - April 2013 Catalog | 15
Short Course Title Conference / Date / LocationPEPTalk
protein Charge Measurement: Why, What and How January 20, 2013 • palm Springs, CA
Buffer optimization for Purifying Proteins January 20, 2013 • palm Springs, CA
What’s new with Peptides January 20, 2013 • palm Springs, CA
Protein Production in the Baculovirus/Insect Cell Expression System January 20, 2013 • palm Springs, CA
How to Obtain Reliable Information from Light Scattering: Theory, practical Advice and Data Interpretation
January 22, 2013 • palm Springs, CA
Flow Cytometry as a Tool for HTp protein purification January 22, 2013 • palm Springs, CA
antibody-Drug Conjugates-Engineering for Success January 22, 2013 • palm Springs, CA
Transient Protein Production in Mammalian Cells January 22, 2013 • palm Springs, CA
Integrating Human Factors engineering (HFe) into Drug Delivery: Get it Right the First Time January 22, 2013 • palm Springs, CA
SCoPE
optimizing the grants Payment Process February 4, 2013 • Miami, FL
Clinical Trial Monitoring and Compliance: The Role of the CRa in Supporting Subject Recruitment and Successful Study Conduct
February 4, 2013 • Miami, FL
Understanding and Implementation of the affordable Care act and Sunshine act on Clinical Trial Management
February 4, 2013 • Miami, FL
applying SharePoint to Some of the Biggest Clinical operations Challenges February 4, 2013 • Miami, FL
Developing and Implementing a Core Team Process for Efficient Sponsor-CRo-Investigative Center Communication and Rapid Study Start-Up
February 4, 2013 • Miami, FL
next-generation Tools to Mitigate Drug-Induced adverse Events February 4, 2013 • Miami, FL
MolECUlaR MED TRI-Con
Targeting Cancer Stem Cells February 11, 2013 • San Francisco, CA
genomics in Medicine February 11, 2013 • San Francisco, CA
Point-of-Care Diagnostics February 11, 2013 • San Francisco, CA
Quantitative Real-Time PCR February 11, 2013 • San Francisco, CA
next generation Pathology February 11, 2013 • San Francisco, CA
Emerging Molecular Diagnostics Partnering Forum February 11, 2013 • San Francisco, CA
Identification & Characterization of Cancer Stem Cells February 12, 2013 • San Francisco, CA
Commercialization Boot Camp: Manual for Success in the Molecular Diagnostics Marketplace February 12, 2013 • San Francisco, CA
ngS Data and the Cloud February 12, 2013 • San Francisco, CA
Best Practices in Personalized and Translational Medicine February 12, 2013 • San Francisco, CA
latest advances in Molecular Pathology February 12, 2013 • San Francisco, CA
Regulatory approval of a Therapeutic & Companion Diagnostic: nuts & Bolts February 12, 2013 • San Francisco, CA
PCR Part I: qPCR in Molecular Diagnostics February 12, 2013 • San Francisco, CA
PCR Part II: Digital PCR applications and advances February 12, 2013 • San Francisco, CA
Samples Prep and Bioorepositories for Cancer Research February 12, 2013 • San Francisco, CA
next-generation Sequencing in Molecular Pathology: Challenges and applications February 12, 2013 • San Francisco, CA
Strategies for Companion Diagnostics Development February 12, 2013 • San Francisco, CA
Patient-Derived Cancer Tissue Xenograph Models February 12, 2013 • San Francisco, CA
Regulatory Strategies for Cell Therapy February 12, 2013 • San Francisco, CA
Microfluidics Technology and Market Trends February 12, 2013 • San Francisco, CA
open Cloud & Data Science February 12, 2013 • San Francisco, CA
Short Course Schedule
October 2012 - April 2013 Catalog | 16 healthtech.com
Cambridge Healthtech Institute250 First Avenue, Suite 300 | Needham, MA 02494
T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288 | F: (781) 972-5425
Your Life Science NetworkCambridge Healthtech Institute